Cartesian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	118.64	125.14	212.61	76.91	106.44	114.06
Short-Term Investments	-	-	-	-	28.16	14
Cash & Short-Term Investments	118.64	125.14	212.61	76.91	134.6	128.06
Cash Growth	-34.25%	-41.14%	176.44%	-42.86%	5.11%	-7.66%
Accounts Receivable	0.26	1.12	0.87	5.87	6.6	9.91
Other Receivables	-	-	-	2.98	3.16	-
Total Trade Receivables	0.26	1.12	0.87	8.85	9.76	9.91
Other Current Assets	3.14	3.02	3.14	4.97	3.78	6.47
Total Current Assets	122.04	129.28	216.63	90.73	148.14	144.44
Net Property, Plant & Equipment	17	17.79	15.45	12.18	14.41	11.97
Other Intangible Assets	93.9	93.9	150.6	150.6	-	-
Goodwill	48.16	48.16	48.16	48.16	-	-
Long-Term Investments	-	-	2	2	2	2
Other Long-Term Assets	7.29	7.29	2.19	1.38	1.34	1.47
Total Assets	288.39	296.41	435.02	305.05	165.89	159.88
Accounts Payable	1.6	1.29	0.29	3.15	0.32	0.22
Accrued Expenses	10.16	9.5	12.08	15.57	14.08	10.53
Short-Term Debt	-	-	-	-	8.48	5.96
Current Portion of Leases	4.19	4.15	2.85	2.17	1.61	-
Unearned Revenue	-	-	-	2.31	0.59	53.88
Other Current Liabilities	-	-	7.76	45.01	-	-
Total Current Liabilities	15.95	14.94	22.98	68.21	25.08	72.25
Long-Term Debt	-	-	-	-	17.79	19.67
Long-Term Leases	7.67	8.53	11.13	8.79	10.06	8.6
Other Long-Term Liabilities	412.9	399.19	407.72	367.68	19.14	36.84
Total Long-Term Liabilities	420.56	407.71	418.85	376.47	46.98	65.11
Total Liabilities	436.51	422.65	441.83	444.68	72.06	137.36
Common Stock	0	0	0	0	0	0.01
Additional Paid-in Capital	718.02	700.71	689.89	179.06	493.31	457.39
Accumulated Other Comprehensive Income	-4.58	-4.58	-4.62	-4.6	-4.56	-4.57
Retained Earnings	-861.56	-822.37	-692.07	-614.65	-394.94	-430.32
Total Common Shareholders' Equity	-148.12	-126.24	-6.8	-440.18	93.83	22.52
Minority Interest	-	-	-	300.55	-	-
Shareholders' Equity	713.44	696.13	685.27	-139.63	93.81	22.52
Total Liabilities & Equity	288.39	296.41	435.02	305.05	165.89	159.88
Total Debt	11.86	12.68	13.98	10.96	37.93	34.23
Net Cash (Debt)	106.79	112.46	198.63	65.96	96.68	93.82
Net Cash Growth	-5.05%	-43.38%	201.15%	-31.78%	3.04%	-10.00%
Net Cash Per Share	4.06	4.33	11.44	0.45	0.66	0.82
Book Value	-148.12	-126.24	-6.8	-440.18	93.83	22.52
Book Value Per Share	-5.63	-4.86	-0.39	-3.02	0.64	0.20
Tangible Book Value	-290.18	-268.3	-205.57	-638.95	93.83	22.52
Tangible Book Value Per Share	-11.02	-10.33	-11.84	-4.38	0.64	0.20

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q